Filing Details
- Accession Number:
- 0001209191-15-072320
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-09-28 17:15:25
- Reporting Period:
- 2015-09-24
- Filing Date:
- 2015-09-28
- Accepted Time:
- 2015-09-28 17:15:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1439222 | Agios Pharmaceuticals Inc | AGIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1581992 | Glenn Goddard | C/O Agios Pharmaceuticals, Inc. 88 Sidney Street Cambridge MA 02139 | Senior Vice President, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-09-24 | 10,000 | $0.00 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-24 | 4,856 | $88.89 | 5,144 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2015-09-24 | 856 | $23.10 | 6,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-09-24 | 6,000 | $85.97 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted stock units | Disposition | 2015-09-24 | 10,000 | $0.00 | 10,000 | $0.00 |
| Common Stock | Stock option (right to buy) | Disposition | 2015-09-24 | 856 | $0.00 | 856 | $23.10 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 88,242 | 2023-08-27 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- This exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $85.09 to $87.70. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The restricted stock units were granted on September 24, 2014 and vested in full on September 24, 2015.
- This option was granted on August 28, 2013. The shares underlying this option vest as to 25% of the underlying shares on August 28, 2014, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
